Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab due to side effects.
Academic Article
Publication Date:
2006
Iris type:
1.1 Articolo in rivista
Keywords:
Etanercept; infliximab; rheumatoid arthritis
List of contributors:
Montecucco, Carlomaurizio; Iannone, F; Trotta, F; Giacomelli, R; Galeazzi, M; Matucci Cerinic, M; Ferri, C; Cutolo, M; Bambara, Lm; Triolo, G; Ferraccioli, G; Valentini, G; Lapadula, G.
Published in: